Layoffs at Theravance Biopharma
- Layoff events
- 2
- verified and sourced
- Roles reported
- Not stated
- no source gives a number
- Announced between
- Feb 2023 to Mar 2026
- Reported by
- U.S. Securities and Exchange Commission, Theravance Biopharma, and Fierce Biotech
This page records what we could verify and source. It is not a complete record of every job cut at Theravance Biopharma: a layoff nobody published and nobody sent us is a layoff that is not on this page.
| Company | What happened | Roles reported | Share of staff | Where | Announced | Sources |
|---|---|---|---|---|---|---|
| Theravance Biopharma |
Pipeline setback
After the Phase 3 CYPRESS study missed its primary endpoint, Theravance announced a restructuring expected to affect approximately 50% of its workforce and wind down R&D. |
Not known | 50% | Company-wide | ||
| Theravance Biopharma |
Restructuring
Theravance Biopharma announced a 17% workforce reduction as part of a pipeline cleanup. |
Not known | 17% | Company-wide |
1 source for Theravance Biopharma |
Where this comes from
Every cut listed for Theravance Biopharma was entered by a person who checked it against a filing or a named report. Nothing is scraped and nothing publishes itself. What is not here is what we have not verified, not what did not happen.
Spotted something wrong or missing about Theravance Biopharma? Tell us on our Discord and we will check it.